A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
13h
Missouri healthcare worker who had contact with a hospitalized patient infected with bird flu developed mild respiratory ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback